tiprankstipranks
Trending News
More News >
MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235)
:2235
Hong Kong Market

MicroTech Medical (Hangzhou) Co., Ltd. Class H (2235) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

MicroTech Medical (Hangzhou) Co., Ltd. Class H has a market cap or net worth of HK$2.53B. The enterprise value is HK$762.27M.
Market CapHK$2.53B
Enterprise ValueHK$762.27M

Share Statistics

MicroTech Medical (Hangzhou) Co., Ltd. Class H has 169,235,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding169,235,840
Owned by Insiders
Owned by Institutions

Financial Efficiency

MicroTech Medical (Hangzhou) Co., Ltd. Class H’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -3.15%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-3.15%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee509.76K
Profits Per Employee-93.09K
Employee Count678
Asset Turnover0.16
Inventory Turnover3.20

Valuation Ratios

The current PE Ratio of MicroTech Medical (Hangzhou) Co., Ltd. Class H is -38.19. MicroTech Medical (Hangzhou) Co., Ltd. Class H’s PEG ratio is -0.67.
PE Ratio-38.19
PS Ratio0.00
PB Ratio1.22
Price to Fair Value1.22
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.67

Income Statement

In the last 12 months, MicroTech Medical (Hangzhou) Co., Ltd. Class H had revenue of 345.62M and earned -63.12M in profits. Earnings per share was -0.15.
Revenue345.62M
Gross Profit182.85M
Operating Income-62.46M
Pretax Income-63.15M
Net Income-63.12M
EBITDA-121.38M
Earnings Per Share (EPS)-0.15

Cash Flow

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00

Dividends & Yields

MicroTech Medical (Hangzhou) Co., Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.38
52-Week Price Change57.87%
50-Day Moving Average6.18
200-Day Moving Average5.24
Relative Strength Index (RSI)41.71
Average Volume (3m)129.52K

Important Dates

MicroTech Medical (Hangzhou) Co., Ltd. Class H upcoming earnings date is Aug 27, 2025, TBA (Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date

Financial Position

MicroTech Medical (Hangzhou) Co., Ltd. Class H as a current ratio of 11.41, with Debt / Equity ratio of <0.01%
Current Ratio11.41
Quick Ratio11.11
Debt to Market Cap<0.01
Net Debt to EBITDA13.95
Interest Coverage Ratio0.00

Taxes

In the past 12 months, MicroTech Medical (Hangzhou) Co., Ltd. Class H has paid 30.96K in taxes.
Income Tax30.96K
Effective Tax Rate>-0.01

Enterprise Valuation

MicroTech Medical (Hangzhou) Co., Ltd. Class H EV to EBITDA ratio is -5.91, with an EV/FCF ratio of -3.52.
EV to Sales2.08
EV to EBITDA-5.91
EV to Free Cash Flow-3.52
EV to Operating Cash Flow-5.95

Balance Sheet

MicroTech Medical (Hangzhou) Co., Ltd. Class H has HK$1.71B in cash and marketable securities with ¥165.63K in debt, giving a net cash position of -HK$1.71B billion.
Cash & Marketable SecuritiesHK$1.71B
Total Debt¥165.63K
Net Cash-HK$1.71B
Net Cash Per Share-HK$10.09
Tangible Book Value Per ShareHK$4.62

Margins

Gross margin is 52.91%, with operating margin of -18.07%, and net profit margin of -18.26%.
Gross Margin52.91%
Operating Margin-18.07%
Pretax Margin-18.27%
Net Profit Margin-18.26%
EBITDA Margin-35.12%
EBIT Margin-38.12%

Analyst Forecast

The average price target for MicroTech Medical (Hangzhou) Co., Ltd. Class H is HK$5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetHK$5.50
Price Target Upside-7.09% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score5
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis